| Financial Year |
March 31 2023 |
| Monetary Funds |
474,194,758.88 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
137,471,388.06 |
| Accounts Receivable |
503,710,105.79 |
| Advances to Suppliers |
26,635,584.42 |
| Other Receivables |
45,158,120.39 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
13,499,231.93 |
| Inventories |
458,157,628.29 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
39,769,483.20 |
| Total Current Assets |
1,927,818,271.42 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
42,263,491.45 |
| Investment Properties |
101,209,696.00 |
| Fixed Assetes |
726,214,827.00 |
| Under-construction Projects |
329,732,759.78 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
280,363,571.00 |
| R&D expenses |
16,847,586.83 |
| Goodwill |
85,433,195.65 |
| Long-Term Deferred and Prepaid Expenses |
15,150,018.86 |
| Deferred Income Tax Assets |
59,814,407.62 |
| Other Non-Current Assets |
161,761,677.70 |
| Sub-Total of Non-Current Assets |
1,820,226,462.26 |
| Total Assets |
3,748,044,733.68 |
| Short-Term Loans |
294,582,208.51 |
| Trading Financial liabilities |
-- |
| Notes Payable |
632,469,347.84 |
| Accounts Payable |
769,555,447.95 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
30,275,211.48 |
| Taxes Payable |
4,485,160.95 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
73,507,887.81 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
96,672,113.56 |
| Other Current Liabilities |
836,071.51 |
| Sub-Total of Current Liabilities |
1,912,370,035.17 |
| Long-term Loans |
303,960,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
99,465,597.81 |
| Special Payable |
-- |
| Estimatied Liabilities |
58,702,288.83 |
| Deferred Income Tax Liabilities |
11,112,176.88 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
568,880,819.17 |
| Total Liabilities |
2,481,250,854.34 |
| Paid-In Capital(Or Share Stock) |
498,719,930.00 |
| Capital Surplus |
1,867,303,208.48 |
| Surplus Reserve |
38,369,508.69 |
| LESS:Treasury Stock |
71,086,750.00 |
| Undistributed Profits |
-1,068,959,102.27 |
| Minority Stockholder's Interest |
2,348,181.59 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,264,445,697.75 |
| Owner's Equity（Stockholder's Equity） |
1,266,793,879.34 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,748,044,733.68 |
